AbbVie Inc. (LON:0QCV)
London · Delayed Price · Currency is GBP · Price in USD 195.60
+5.09 (2.67%)
At close: Aug 1, 2025
AbbVie Market Cap
AbbVie has a market cap or net worth of 260.33 billion as of August 1, 2025. Its market cap has increased by 12.88% in one year.
Market Cap
260.33B
Enterprise Value
309.32B
Revenue
42.57B
Ranking
n/a
PE Ratio
95.80
Stock Price
195.60
Market Cap Chart
Since December 10, 2012, AbbVie's market cap has increased from 34.43B to 260.33B, an increase of 656.11%. That is a compound annual growth rate of 17.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 252.49B | 0.66% |
| Dec 31, 2024 | 250.83B | 16.77% |
| Dec 29, 2023 | 214.80B | -9.41% |
| Dec 30, 2022 | 237.12B | 34.13% |
| Dec 31, 2021 | 176.78B | 27.59% |
| Dec 31, 2020 | 138.56B | 40.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 173.02B |
| GSK plc | 59.04B |
| Haleon | 32.99B |
| Smith & Nephew | 10.33B |
| ConvaTec Group | 5.00B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 2.45B |
| Oxford Nanopore Technologies | 1.97B |